The global urinalysis market is marked by fierce competition among the leading players. Most companies are keen on developing new technology to improve efficiency of test results and reduce time. Another area of research focus for big companies is reduction of cost. These factors are maintaining a competitive spirit in the urinalysis market. Further, key brands are also looking at acquiring smaller and regional players with patented products to expand their global footprint.
Some of the prominent companies in the global urinalysis market are Siemens Healthcare, BAYER Healthcare, and F.Hoffman- La Roche Ltd. The top five players in the market alone held 41% of the total share in 2016, analysts said.
The global urinalysis market stood at US$ 929.9 mn at the end of 2016. The market is expected to grow at a promising CAGR of 5.4%, and is predicted to attain a total value of US$ 1.5 bn by the end of 2024.
Based on test setting, laboratory based segment is predicted to emerge as the leading shareholder. With flourishing private healthcare facilities in developing and developed countries, the need for private laboratories is rising. Further, the need for quicker and cost-efficient laboratory facilities will also boost demand for urinalysis products in the market.
Geographically, Asia Pacific is expected to emerge as the highest shareholder in the global urinalysis market. Developing countries like India and China are increasing their focus on healthcare, thus promoting growth in the market.
Growing Diabetic Population to Drive Urinalysis Market
Besides measuring sugar levels in the blood, doctors also monitor it in the urine samples of patients. The rising diabetic population is believed to be a key driver for the global urinalysis market. Not only senior citizens, but children and young adults are also becoming victims of diabetes. In diabetes, it is essential for patients to periodically visit the doctor. These factors are believed to enhance demand for urinalysis products.
Another key driver for the global urinalysis market is the rising number of surgeries and healthcare procedures. With rise in number of diseases and increasing awareness about healthcare, people are prompt to receive treatment at an early stage. Further, support from government and availability of private health insurance eases people’s burden to undergo expensive and complicated surgeries. Patients have to undergo a series of tests before a surgery, of which one of them is urinalysis. The urine samples are tested for presence of bacteria and sugar levels. These aspects are predicted to support demand for urinalysis products in the forecast period.
High Cost Could Deter Growth in the Urinalysis Market
While there are several factors the aid growth in the global urinalysis market. But, there are restraints that could restrict growth. One of them is cost as the equipment is expensive, the cost of tests are also high. This makes it difficult for people in the lower economic strata to afford these procedures.
A relief for players in the urinalysis market is the growing investments in R&D to develop low-cost and efficient products. Further, subsidies from government for poor and support from corporate and non-governmental organizations is also predicted to improve demand in the coming years.
The study presented here is based on a Transparency Market Research report titled “Urinalysis Market (Product Type – Instruments (Chemistry Analyzer, Microscopy Analyzer/Sediment Analyzer, Integrated Chemistry and Sediment Analyzer, and Portable Analyzers) and Consumables (Plastic Consumables, Reagent Strips, and Chemical Agents); Test Type – Macroscopic, Biochemical, and Sediment/Microscopic; Test Setting – Point-of-care and Laboratory-based; End User – Hospitals, Independent Laboratories, and Physician Practices) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”
This post was originally published on Market Reports